Simplified silvestrol analogues with potent cytotoxic activity. 2014

Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052 (Australia); Department of Medical Biology, The University of Melbourne, VIC 3010 (Australia).

The complex natural products silvestrol (1) and episilvestrol (2) are inhibitors of translation initiation through binding to the DEAD-box helicase eukaryotic initiation factor 4A (eIF4A). Both compounds are potently cytotoxic to cancer cells in vitro, and 1 has demonstrated efficacy in vivo in several xenograft cancer models. Here we show that 2 has limited plasma membrane permeability and is metabolized in liver microsomes in a manner consistent with that reported for 1. In addition, we have prepared a series of analogues of these compounds where the complex pseudo-sugar at C6 has been replaced with chemically simpler moieties to improve drug-likeness. Selected compounds from this work possess excellent activity in biochemical and cellular translation assays with potent activity against leukemia cell lines.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D039601 Eukaryotic Initiation Factor-4A A component of eukaryotic initiation factor 4F that as an RNA helicase involved in unwinding the secondary structure of the 5' UNTRANSLATED REGION of MRNA. The unwinding facilitates the binding of the 40S ribosomal subunit. EIF-4A,Peptide Initiation Factor EIF-4A,EIF-4A1,EIF-4A2,EIF-4A3,EIF4AIII,Eukaryotic Initiation Factor EIF-4A,Eukaryotic Initiation Factor-4A1,Eukaryotic Initiation Factor-4A2,Eukaryotic Initiation Factor-4A3,Eukaryotic Peptide Initiation Factor-4A,Eukaryotic Translation-Initiation Factor 4AIII,Eukaryotic Initiation Factor 4A,Eukaryotic Initiation Factor 4A1,Eukaryotic Initiation Factor 4A2,Eukaryotic Initiation Factor 4A3,Eukaryotic Initiation Factor EIF 4A,Eukaryotic Peptide Initiation Factor 4A,Eukaryotic Translation Initiation Factor 4AIII,Factor-4A1, Eukaryotic Initiation,Factor-4A2, Eukaryotic Initiation,Factor-4A3, Eukaryotic Initiation,Initiation Factor-4A, Eukaryotic,Initiation Factor-4A1, Eukaryotic,Initiation Factor-4A2, Eukaryotic,Initiation Factor-4A3, Eukaryotic,Peptide Initiation Factor EIF 4A

Related Publications

Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
October 2012, Journal of medicinal chemistry,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
March 2008, Journal of medicinal chemistry,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
October 2006, Journal of medicinal chemistry,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
May 2009, Journal of medicinal chemistry,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
January 2012, Bioorganic & medicinal chemistry letters,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
November 2004, The journal of peptide research : official journal of the American Peptide Society,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
April 2006, Journal of medicinal chemistry,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
August 2015, ChemMedChem,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
September 1998, Proceedings of the National Academy of Sciences of the United States of America,
Bill C Hawkins, and Lisa M Lindqvist, and Duong Nhu, and Phillip P Sharp, and David Segal, and Andrew K Powell, and Michael Campbell, and Eileen Ryan, and Jennifer M Chambers, and Jonathan M White, and Mark A Rizzacasa, and Guillaume Lessene, and David C S Huang, and Christopher J Burns
July 2007, Journal of medicinal chemistry,
Copied contents to your clipboard!